Alterations to brain vascular function, supported by the downregulated expression of NOS3, NOTCH3, MYH11, MYL9, and TAGLN, is another distinguishing pathological feature in ALS-Ox patients. This evidence concerns the gene TAGLN and amyotrophic lateral sclerosis.